Disclaimer: The below article is sponsored, and the views in it do not represent those of ZyCrypto. Readers should conduct independent research before taking any actions related to the project mentioned in this piece. This article should not be regarded as investment advice.
BioSig Technologies and Streamex have entered a merger to bring real-world asset tokenization to the U.S. market. Streamex Exchange Corporation is a private entity specializing in the tokenization of real-world assets (RWAs), with a particular focus on the commodities sector.
By merging with BioSig, the company will diversify BioSig’s offerings and position the combined company to lead the emerging market of regulated RWA tokenization in the United States.
Streamex will offer five major products by developing compliant primary issuance and decentralized exchange infrastructure, aiming to modernize commodity markets. The offerings include access, diversification, innovation, legal framework, and security.
The company will create access by connecting over 500 million new users to a market with $3 trillion in liquidity. By providing access to a variety of private placements in traditional capital markets, Streamex will also be bringing diversity to the industry.
 
Innovation will also see a significant boost as it creates and owns individualized royalties and streaming contracts through tokenization, while establishing a legal framework in collaboration with regulators to ensure a safe and stable environment.
Finally, the company aims to enhance security in the WRWA market in the U.S. by leveraging automation and blockchain technology for secure financing documentation.
Details of the merger reveal that BioSig and Streamex have completed a definitive share exchange agreement, which makes Streamex a wholly owned subsidiary of BioSig. Consequently, Streamex’s shareholders will receive a substantial share allocation in BioSig.
This will transform the company into a pioneer in the blockchain space, with plans to enhance the tokenization of physical assets, including gold and commodities, and accelerate the adoption of blockchain technology in commodity finance within the approximately $142 trillion global commodities market.
Additionally, BioSig has recently engaged the Compliance Exchange Group (CXG) to assist in acquiring a FINRA- and SEC-registered broker-dealer. This will position Streamex as one of the first publicly traded, fully regulated RWA tokenization companies in the U.S.
This way, Streamex can issue and trade tokenized assets in compliance with federal securities laws, expanding its market presence and providing institutional and retail players with access to gold-backed digital opportunities.
When complete, Streamex will bridge tradfi and blockchain, providing compliant and straightforward access to the $22 trillion gold market through digital tokens.
Already, the merger and acquisitions have led to a 24.4% surge in BioSig’s stock following the announcement of the share exchange. Additionally, analysts predict that the transition from a traditional medtech company to a multi-faceted player in the blockchain and digital asset arena could raise its earnings by 73.3% in 2025.
Under the leadership of Henry McPhie, the two companies in one are set to revolutionize the way users access real-world assets through blockchain technology through their commitment to compliance, innovation, and market expansion, which places them on the path to redefine traditional finance, bringing unprecedented opportunities in the blooming world of RWA tokenization.
Source: https://zycrypto.com/biosig-technologies-and-streamex-join-forces-to-pioneer-real-world-asset-tokenization-in-the-u-s-market/